Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation: Pidotimod in SARS-CoV-2 vaccination. (2022). Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022023. https://doi.org/10.4084/MJHID.2022.023